Cargando…
Pharmacology of Recombinant Adeno-associated Virus Production
Recombinant adeno-associated viral (rAAV) vectors have been used in more than 150 clinical trials with a good safety profile and significant clinical benefit in many genetic diseases. In addition, due to their ability to infect non-dividing and dividing cells and to serve as efficient substrate for...
Autores principales: | Penaud-Budloo, Magalie, François, Achille, Clément, Nathalie, Ayuso, Eduard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908265/ https://www.ncbi.nlm.nih.gov/pubmed/29687035 http://dx.doi.org/10.1016/j.omtm.2018.01.002 |
Ejemplares similares
-
Chemical modification of the adeno-associated virus capsid to improve gene delivery
por: Mével, Mathieu, et al.
Publicado: (2019) -
Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCR
por: D’Costa, Susan, et al.
Publicado: (2016) -
Accurate Titration of Infectious AAV Particles Requires Measurement of Biologically Active Vector Genomes and Suitable Controls
por: François, Achille, et al.
Publicado: (2018) -
Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNA
por: Dupont, Jean-Baptiste, et al.
Publicado: (2015) -
Adeno-Associated Viral Vector-Mediated Transgene Expression Is Independent of DNA Methylation in Primate Liver and Skeletal Muscle
por: Léger, Adrien, et al.
Publicado: (2011)